These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10325574)

  • 1. Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia.
    Chandra S; White RF; Everding D; Feuerstein GZ; Coatney RW; Sarkar SK; Barone FC
    Pharmacology; 1999 Jun; 58(6):292-9. PubMed ID: 10325574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain MRI and neurological deficit measurements in focal stroke: rapid throughput validated with isradipine.
    Lenhard SC; Strittmatter R; Price WJ; Chandra S; White RF; Barone FC
    Pharmacology; 2008; 81(1):1-10. PubMed ID: 17726342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of isradipine to reduce infarct size in mouse, gerbil, and rat models of cerebral ischemia.
    Bailey SJ; Wood NI; Samson NA; Rothaul AL; Roberts JC; King PD; Hamilton TC; Harrison DC; Hunter AJ
    Stroke; 1995 Nov; 26(11):2177-83. PubMed ID: 7482669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists for reduction of brain damage in stroke.
    Sauter A; Rudin M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S43-7. PubMed ID: 1695302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI.
    Yenari MA; Palmer JT; Sun GH; de Crespigny A; Mosely ME; Steinberg GK
    Brain Res; 1996 Nov; 739(1-2):36-45. PubMed ID: 8955922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats.
    Hu S; Dong H; Zhang H; Wang S; Hou L; Chen S; Zhang J; Xiong L
    Brain Res; 2012 Jun; 1459():81-90. PubMed ID: 22560096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
    Gupta S; Sharma U; Jagannathan NR; Gupta YK
    Exp Neurol; 2017 Feb; 288():25-37. PubMed ID: 27794423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animals.
    Sauter A; Rudin M
    Am J Med; 1989 Apr; 86(4A):130-3. PubMed ID: 2523648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of stroke and brain damage with calcium antagonists in animals.
    Sauter A; Rudin M
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):121S-127S. PubMed ID: 1827001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology.
    Gill R; Sibson NR; Hatfield RH; Burdett NG; Carpenter TA; Hall LD; Pickard JD
    J Cereb Blood Flow Metab; 1995 Jan; 15(1):1-11. PubMed ID: 7798326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats.
    Tian J; Fu F; Geng M; Jiang Y; Yang J; Jiang W; Wang C; Liu K
    Neurosci Lett; 2005 Feb; 374(2):92-7. PubMed ID: 15644271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation.
    Huang YC; Tzeng WS; Wang CC; Cheng BC; Chang YK; Chen HH; Lin PC; Huang TY; Chuang TJ; Lin JW; Chang CP
    Magn Reson Imaging; 2013 Sep; 31(7):1174-81. PubMed ID: 23642800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals.
    Sauter A; Rudin M; Wiederhold KH; Hof RP
    Am J Med; 1989 Apr; 86(4A):134-46. PubMed ID: 2523649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia.
    Belayev L; Zhao W; Pattany PM; Weaver RG; Huh PW; Lin B; Busto R; Ginsberg MD
    Stroke; 1998 Dec; 29(12):2587-99. PubMed ID: 9836772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists.
    Sauter A; Rudin M; Wiederhold KH
    Neurochem Pathol; 1988; 9():211-36. PubMed ID: 3073331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging.
    Sauter A; Rudin M
    Stroke; 1986; 17(6):1228-34. PubMed ID: 2949398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats.
    Chauhan A; Sharma U; Jagannathan NR; Reeta KH; Gupta YK
    Behav Brain Res; 2011 Dec; 225(2):603-9. PubMed ID: 21903138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
    Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
    Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.